Survival and drug resistance mechanisms of ovarian carcinoma cells in effusions
- Prosjektnummer
- 2008035
- Ansvarlig person
- Ben Davidson
- Institusjon
- Rikshospitalet-Radiumhospitalet HF
- Prosjektkategori
- Korttidsprosjekt
- Helsekategori
- Pathology
- Forskningsaktivitet
- Frie prosjekter - basalforskning
Cleaved caspase-3 and nuclear factor-kappaB p65 are prognostic factors in metastatic serous ovarian carcinoma.
Hum Pathol 2009 Jun;40(6):795-806. Epub 2009 jan 20
PMID: 19157506
Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
Hum Pathol 2009 Jan. Epub 2009 jan 2
PMID: 19121847
Ovarian carcinoma cells in effusions show increased S-phase fraction compared to corresponding primary tumors.
Diagn Cytopathol 2008 Sep;36(9):637-44.
PMID: 18677760
Different clinical roles for p21-activated kinase-1 in primary and recurrent ovarian carcinoma.
Hum Pathol 2008 Jul. Epub 2008 jul 23
PMID: 18656238
Methods for simultaneous measurement of apoptosis and cell surface phenotype of epithelial cells in effusions by flow cytometry.
Nat Protoc 2008;3(6):955-64.
PMID: 18546596
Death receptor expression is associated with poor response to chemotherapy and shorter survival in metastatic ovarian carcinoma.
Cancer 2008 Jan;112(1):84-93.
PMID: 17985388
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport